{"nctId":"NCT01954121","briefTitle":"Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures","startDateStruct":{"date":"2013-09"},"conditions":["Epilepsy","Partial Seizures"],"count":436,"armGroups":[{"label":"Levetiracetam","type":"EXPERIMENTAL","interventionNames":["Drug: Levetiracetam"]},{"label":"Carbamazepine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Carbamazepine"]}],"interventions":[{"name":"Levetiracetam","otherNames":["Keppra"]},{"name":"Carbamazepine","otherNames":["Tegretol"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subject is of Chinese origin and â‰¥ 16 years of age\n* Subject is newly or recently diagnosed with Epilepsy, having experienced unprovoked Partial-Onset Seizures (POS)\n* Subject has experienced at least 2 unprovoked seizures in the year preceding randomization, of which at least 1 unprovoked seizure occurred in the 3 months preceding randomization\n* Subject has had an Electroencephalogram (EEG) and a brain Computed Tomography (CT) scan or brain Magnetic Resonance Imaging (MRI) scan consistent with a diagnosis of Epilepsy with POS\n\nExclusion Criteria:\n\n* Subject tests positive for human leukocyte antigen major histocompatibility complex, class I,B (HLA-B)\\* 1502 allele\n* Subject has a history or presence of seizures of other types than Partial-Onset Seizures (POS)\n* Subject has only experienced type IA nonmotor seizures\n* Subject has a history or presence of seizures occurring only in clustered patterns\n* Subject has a history of clinical or Electroencephalogram (EEG) findings suggestive of Idiopathic Generalized Epilepsy prior to randomization\n* Subject has current or previous diagnosis of pseudoseizures, conversion disorders, or other nonepileptic ictal events that could be confused with seizures\n* Subject has a history of Status Epilepticus","healthyVolunteers":false,"sex":"ALL","minimumAge":"16 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Proportion of Subjects Remaining Seizure Free During the 6-months Evaluation Period","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.3","spread":null},{"groupId":"OG001","value":"68.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Subjects Retained in the Study for the Duration of the Period Covering the Up Titration Period, Stabilization Period, and Evaluation Period","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.4","spread":null},{"groupId":"OG001","value":"70.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to First Seizure or Discontinuation Due to an Adverse Event (AE) / Lack of Efficacy (LOE) During the Evaluation Period","description":"Number of qualifying events is reported because it is the only descriptive measure available from the proportional hazards model, that was applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to First Seizure During the Evaluation Period","description":"Number of qualifying events is reported because it is the only descriptive measure available from the proportional hazards model, that was applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"87","spread":null},{"groupId":"OG001","value":"39","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to First Seizure During the Period Covering the Up Titration Period, Stabilization Period, and Evaluation Period From the First Dose of Study Drug","description":"Number of qualifying events is reported because it is the only descriptive measure available from the proportional hazards model, that was applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"97","spread":null},{"groupId":"OG001","value":"57","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":218},"commonTop":["Nasopharyngitis","Dizziness","Headache","Upper respiratory tract infection","Somnolence"]}}}